DREAM complex

The dimerization partner, RB-like, E2F and multi-vulval class B (DREAM) complex is a protein complex responsible for the regulation of cell cycle-dependent gene expression. The complex is evolutionarily conserved, although some of its components vary from species to species. In humans, the key proteins in the complex are RBL1 (p107) and RBL2 (p130), both of which are homologs of RB (p105) and bind E2F transcription factors; E2F4 and E2F5 transcription factors which repress gene expression; DP1, DP2 and DP3, dimerization partners of E2F; and MuvB, which is a complex of LIN9/37/52/54 and RBBP4.
Function.
The main function of the DREAM complex is to repress gene expression during quiescence (G0). One of the genes repressed is the proto-oncogene Myc. Entry into G1 causes the dissociation of p130 from the complex, which prevents E2F4/5 from binding gene promoters. BMYB, which is repressed by the DREAM complex during G0 is expressed during G1 and it subsequently binds to MuvB during S phase to promote the expression of key G2/M phase genes such as CDK1 and CCNB1. FOXM1 is then recruited in G2 to further promote gene expression (e.g. AURKA). During late S phase BMYB is degraded via CUL1 (SCF complex), while FOXM1 is degraded during mitosis by the APC/C. The DREAM complex regulates cytokinesis through GAS2L3.
In "Drosophila melanogaster" there is a testis-specific paralog of the Myb-MuvB/DREAM complex known as tMAC (testis-specific meiotic arrest complex), which is involved in meiotic arrest.
Apart from its role in cell cycle control, the DREAM complex has been shown to be involved in the programmed cell death of neural precursor cells in "Drosophila melanogaster".
Cancer therapy.
Due to its regulatory role in the cell cycle, targeting the DREAM complex might enhance anticancer treatments such as imatinib.